Remission and relapse of diabetes after sleeve gastrectomy and one‐anastomosis gastric bypass: The Tehran Obesity Treatment Study

Sara Sadeghi,Farhad Hosseinpanah,Alireza Khalaj,Amir Ebadinejad,Maryam Mahdavi,Majid Valizadeh,Maryam Barzin
DOI: https://doi.org/10.1111/dom.15974
2024-10-02
Diabetes Obesity and Metabolism
Abstract:Aims To evaluate the rates and predictors of remission and relapse of type 2 diabetes mellitus (T2DM) in individuals with T2DM undergoing sleeve gastrectomy (SG) or one‐anastomosis gastric bypass (OAGB). Methods An observational prospective study with 5 years of follow‐up was conducted in a total of 891 patients (82.5% female) with concomitant T2DM and obesity (body mass index ≥ 30.0 kg/m2) undergoing SG or OAGB between March 2013 and March 2021. T2DM remission was defined as achieving a glycated haemoglobin (HbA1c) level
endocrinology & metabolism
What problem does this paper attempt to address?